MedPath

SAUDI PHARMACEUTICAL INDUSTRIES AND MEDICAL APPLIANCES CORPORATION

🇸🇦Saudi Arabia
Ownership
-
Employees
-
Market Cap
$1.1B
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

387

SFDA:387

Drug Approvals

AZOLID 250MG F.C. TABLETS

Approval Date
Jul 18, 2025
SFDA

CO-VALISTA

Approval Date
Jul 18, 2025
SFDA

SAPOFEN 600 MG TAB

Approval Date
Jul 18, 2025
SFDA

Carcivor 250 mg per 5 ml

Approval Date
Jul 18, 2025
Company
laboratories farmalan sa
SFDA

BANORIV 15MG F.C.TABLET

Approval Date
Jul 18, 2025
SFDA

EZORA 40 MG GASTRO-RESISTANT HARD CAPSULES (28S)

Approval Date
Jul 18, 2025
Company
towa pharmaceutical europe s l
SFDA

IMUTIN 400 MG CAPSULE

Approval Date
Jul 18, 2025
Company
adamed pharma s.a
SFDA

FUNGISKA 50 mg Vial

Approval Date
Jul 18, 2025
Company
mefar ilac sanayii a.s.
SFDA

CANDEZA 16/12.5 mg TABLETS

Approval Date
Jul 18, 2025
Company
BLUEPHARMA - INDÚSTRIA FARMACÊUTICA, S.A.
SFDA

FORMIT XR 750 MG TABLETS

Approval Date
Jul 18, 2025
SFDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 39
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.